评论 | 发展健康产业需用更多好"药方"_新闻频道_中山网 zsnews.cn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from zsnews.cn Daily Mail and Mail on Sunday newspapers.
[HK]康方生物-B:自愿公告 - 获纳入MSCI中国指数- CFi.CN 中财网 cfi.net.cn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cfi.net.cn Daily Mail and Mail on Sunday newspapers.
抗癌药全球最大"灵活工厂"落户广州 大湾区生物医药自主产能再提升 ycwb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ycwb.com Daily Mail and Mail on Sunday newspapers.
康方药业一期在穗投产,全球首款双特异性抗体新药或今年上市 oeeee.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from oeeee.com Daily Mail and Mail on Sunday newspapers.
[HK]康方生物-B:自愿公告 - 派安普利单抗(PD-1)联合化疗一线治疗鳞状非小细胞肺癌的III期临床试验中期分析达到主要终点- CFi.CN 中财网 cfi.net.cn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cfi.net.cn Daily Mail and Mail on Sunday newspapers.
[HK]康方生物-B:自愿公告 - CADONILIMAB(PD-1/CTLA-4双特异性抗体)联合化疗一线治疗晚期胃癌或胃食管结合部腺癌IB/II期研究最新结果在2021 ASCO GI上发布- CFi.CN 中财网 cfi.net.cn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cfi.net.cn Daily Mail and Mail on Sunday newspapers.
[HK]康方生物-B:自愿公告-派安普利单抗(PD-1)联合安罗替尼一线治疗晚期肝癌的最新研究在2021 ASCO GI上发布- CFi.CN 中财网 cfi.net.cn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cfi.net.cn Daily Mail and Mail on Sunday newspapers.